Drug Testing: Special Populations and Additional Considerations in Addiction Treatment Webinar (1 CME)

Product not yet rated

This webinar will help to build knowledge of The ASAM Appropriate Use of Drug Testing in Clinical Addiction Medicine document. The development of the document guides provider decisions about drug testing, as no universal standard exists today. It will also allow patients and their families, healthcare administrators, and payers determine clearly what is appropriate practice and what is considered outside the realm of appropriate practice in regards to drug testing in clinical addiction medicine. 

JoAn Laes


JoAn Laes, MD, Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN; Core Medical Toxicology Faculty, Minnesota Poison Control System, Minneapolis, MN; Medical Director, Mission Detox Center, Plymouth, MN and 1800 Detox, Minneapolis, MN, ASAM Medical Toxicology workgroup Chair.Dr. Laes' practice is focused on inpatient addiction medicine and toxicology consultation and outpatient treatment of opioid and other substance use disorders. She is board certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s).  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

  • Identify the unique considerations in drug testing for special populations including adolescents and pregnant women. 
  • Summarize the consensus document's recommendations for drug testing for special populations and discuss how they should be used in practice.
  • Analyze the importance of practitioner documentation, confidentiality, language and attitude in addiction treatment.
  • Determine how to appropriately conduct drug testing on-site and/or choose a qualified laboratory.


Webinar Recording
Open to view video.
Open to view video. This webinar was recorded on October 26, 2017.
CME Quiz
3 Questions
3 Questions Please answer this short quiz for CME credit.
CME Evaluation
15 Questions
CME Certificate
Up to 1.00 medical credits available  |  Certificate available
Up to 1.00 medical credits available  |  Certificate available Click to view your certificate.